Alliance for Hippocratic Medicine et al v. U.S. Food and Drug Administration et al
Case Number:
2:22-cv-00223
Court:
Nature of Suit:
Other Statutes: Administrative Procedure Act/Review or Appeal of Agency Decision
Judge:
Firms
- American Center for Law & Justice Inc.
- Bustos Law Firm PC
- Covington & Burling
- Debevoise & Plimpton
- Fillmore Law Firm
- Hogan Lovells
- McCarn & Weir
- Morgan Williamson
- Mullin Hoard
- Perdue Brandon
- Samples Jennings
- Sheppard Mullin
- Shutts & Bowen
- Smith Appellate Law Firm
- Weycer Kaplan
Companies
- American Academy of Family Physicians
- American Medical Association Inc.
- Charlotte Lozier Institute
- Judicial Watch Inc.
Government Agencies
Sectors & Industries:
-
January 23, 2024
3 States Ask To Join High Court Case Against Abortion Drug
Republican attorneys general in Missouri, Idaho and Kansas moved to join the case in the U.S. Supreme Court challenging federal approvals for the abortion medication mifepristone, asking the justices to ensure the challenge isn't dismissed for lack of standing.
-
January 12, 2024
Judge OKs Bid By 3 States To Join Suit Against Abortion Drug
A Texas federal judge granted permission Friday for Missouri, Kansas and Idaho to join a lawsuit challenging federal approvals for the abortion medication mifepristone, ruling that the states have unique interests that aren't represented by others in the case.
-
December 18, 2023
Feds Say 3 States Can't Intervene In Abortion Pill Suit
The federal government asked a Texas court to reject a motion for intervention in a dispute over the abortion drug mifepristone, arguing that there was no point in adding Missouri, Idaho and Kansas to the suit when the original plaintiffs who sued lacked sufficient standing.
-
November 17, 2023
Judge Won't Delay Ruling If States Can Join Abortion Pill Suit
A Texas federal judge told the government to make its argument about why Missouri, Kansas and Idaho shouldn't intervene in a lawsuit over various rulings about the abortion drug mifepristone, saying that there's no need to wait for the U.S. Supreme Court to decide if it will review the case.
-
November 15, 2023
3 States Slam Feds' Request For Pause In Abortion Drug Suit
Missouri, Kansas and Idaho want a Texas federal judge to decide now whether they can join a lawsuit against the U.S. Food and Drug Administration and the U.S. Department of Health and Human Services over the abortion drug mifepristone, instead of waiting to see if the U.S. Supreme Court weighs in on a Fifth Circuit ruling that would limit access to the drug.
-
November 06, 2023
3 States Ask To Join Suit To Halt Access To Abortion Drug
Missouri, Kansas and Idaho have asked to join a lawsuit against the U.S. Food and Drug Administration and the U.S. Department of Health and Human Services over the abortion drug mifepristone, with the states arguing they have special claims and rights to protect in the case.
-
April 12, 2023
Abortion Pill Battle Puts Squeeze On Drug Benefit Managers
A Texas federal court's recent decision upending certification of a pill used to terminate pregnancies will put pressure on the pharmacy benefit managers that act as intermediaries between drugmakers and insurers, attorneys say, heightening PBMs' potential legal exposure at the same time that states are seeking to ramp up regulations.
-
April 10, 2023
Pharma Execs Slam Abortion Pill Ruling, Citing Industry Risk
Chief executive officers and top legal counsel for pharmaceutical and biotech companies, including Pfizer, said a Texas federal judge's Friday order blocking the effective date of the U.S. Food and Drug Administration's decades-old approval of the abortion drug mifepristone fundamentally undermines the agency's authority and threatens industry.
-
April 07, 2023
Texas Judge Pushes Pause On FDA Abortion Drug Approval
A Texas federal judge Friday blocked the effective date of the U.S. Food and Drug Administration's decades-old approval of the abortion drug mifepristone and gave the Biden administration one week to appeal, drawing out a watershed ruling that could dramatically restrict abortion access in the U.S., where medication abortion has become the most common method to terminate pregnancies.
-
March 15, 2023
Texas Judge Challenges Claim Abortion Pill Suit Filed Too Late
A Texas federal judge overseeing a high-profile fight over abortion medication asked the U.S. Food and Drug Administration whether allegations that it unlawfully approved a drug more than 20 years ago were time-barred, noting at a Wednesday hearing that anti-abortion groups claim the agency waited years to take action.